ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   


By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

ThromboGenics NV 

Gaston Geenslaan 1

Heverlee    B-3001  Belgium
Phone: 32-0-16-751310 Fax: 32-0-16-751311


SEARCH JOBS








 Company News
Novartis AG (NVS), Shire Weighing $1.3 Billion Offer For ThromboGenics NV (TBGNF) 4/15/2014 8:02:48 AM    More...
Flailing ThromboGenics NV (TBGNF) Considering Strategic Options 2/24/2014 8:04:47 AM    More...
ThromboGenics NV (TBGNF)' Founder Prof Desire Collen Retiring As Chairman 12/9/2013 6:51:51 AM    More...
ThromboGenics NV (TBGNF)' JETREA® Nominated for 2013 Prix Galien USA 10/21/2013 8:12:43 AM    More...
Germany's G-BA Confirms That ThromboGenics NV (TBGNF)' JETREA® Demonstrates Significant Therapeutic Benefits for Vitreomacular Traction (VMT) Patients, Including When Associated With Macular Hole 10/18/2013 9:37:51 AM    More...
ThromboGenics NV (TBGNF) Establishes Level 1 ADR Program for US Investors 9/30/2013 8:34:09 AM    More...
ThromboGenics NV (TBGNF) Grabs Exclusive Rights to Bicycle Therapeutics Limited's Eye Treatment Technology 9/5/2013 7:12:11 AM    More...
UK's National Institute for Clinical Excellence (NICE) Final Appraisal Determination (FAD) Confirms Positive Recommendation for ThromboGenics NV (TBGNF)' JETREA® for Treatment of Vitreomacular Traction and Macular Hole 9/3/2013 8:06:15 AM    More...
ThromboGenics NV (TBGNF) Business Update H1 2013 8/30/2013 8:40:10 AM    More...
ThromboGenics NV (TBGNF)' JETREA® Receives Positive Initial National Institute for Clinical Excellence (NICE) Recommendation for Vitreomacular Traction and Macular Hole 6/12/2013 9:03:26 AM    More...
123456